1 / 19

Nanomedicine for Cancer Prevention

Nanomedicine for Cancer Prevention. By Curtis Gibson. Nanomedicine. Involves particles on a nanoscale level Can carry tens of thousands of small substances Drugs for treatment delivery Contrast agents for imaging Major areas of use for cancer Prevention and control

cerise
Download Presentation

Nanomedicine for Cancer Prevention

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Nanomedicine for Cancer Prevention By Curtis Gibson

  2. Nanomedicine • Involves particles on a nanoscale level • Can carry tens of thousands of small substances • Drugs for treatment delivery • Contrast agents for imaging • Major areas of use for cancer • Prevention and control • Early detection and proteomes • Imaging diagnostics • Multifunctional therapeutics

  3. Nanomedicine Size • Typically between 10 and 100 nanometers

  4. Nanowires • Act as sensors by detecting cancer proteins • Conductive wires laid along a channel for sample particles to flow through • Use probes such as antibodies or DNA • Complimentary antigens or DNA from the tumor bind to the probes • Reaction changes electrical conductivity • Monitored by an electronic detector • Nanowire animation

  5. Cantilevers • Also used as sensors • Beams of semiconductive material containing probes • Complementary DNA or proteins from the tumor bind to probes • Reaction causes cantilevers to bend slightly • Can even recognize when a single DNA molecule or protein attaches • Process can also be observed electronically • Cantilever animation

  6. Quantum Dots • Used for magnetic resonance imaging • Nanocrystals of semiconductor material • Often cadmium or mercury containing compounds covered with metal or latex • Emit light at certain wavelengths and frequencies • Antibody-antigen complex • Illumination of the dots changes creating a marker for cancer proteins

  7. Nanoshells • Used for imaging and cancer tissue targeting • Composed of a solid core of silica with a surrounding thin metallic layer, often gold • Enter tumor tissue by large pores in the irregular blood vessel walls • Absorb light in the NIR region and convert this to heat destroying cancer cells • Antibodies may also be attached to nanoshells to promote tumor specificity • Nanoshell animation

  8. Nanospheres vs Nanocapsules • Nanospheres • Polymeric matrix with drug covalently bonded and scattered throughout • Nanocapsules • Aqueous or oily core with drug enclosed by a single polymeric membrane • Poly(isobutylcyanoacrylate) for hydrophobic drugs • Poly(ethylene glycol) for hydrophilic drugs

  9. Micelles • Polymeric nanoparticles • Hydrophobic core surrounded by hydrophilic shell • Water soluble and delivered by IVs • Drugs can be covalently bonded to the core or exclusively trapped inside by physical means

  10. Dendrimers • Macromolecules composed of multiple branched polymers emerging for a single radial center • Polymers are all similar in size and are about 1 to 10 nanometers long • Can adjust their surface functionality and can even contain different charges on polymers • Treatment agents can be stored inside the core or attached to polymers outside

  11. Liposomes • Lipid-based drug carriers that are spherical • Contain an outer lipid bilayer that encloses an aqueous inner space • Lipid shells allow liposomes to passively travel through cancer membranes • Therapeutic particles contained in the inner core

  12. Viral Nanoparticles and Nanotubes • Viral nanoparticles • Virus contains antibodies on capsid surface • Drugs contained inside the capsid • Can be combined with fullerenes (C60) to make an even better molecule for delivery • Nanotubes • Cylinders formed from benzene rings • Insoluble but can be made soluble through chemical modifications • Multiple different functional areas on sidewalls and ends

  13. Obstacles of Nanoparticles • Obstacles • Surviving in the bloodstream • Selectively entering tumor cells • Requirements • Must be large enough to avoid escaping into capillaries • Must be small enough to avoid being ingested by macrophages in the reticuloendothelial system • Must have a hydrophilic region to keep proteins from recognizing them as foreign particles

  14. Passive Targeting • Enhanced permeability and retention effect • Cancer cells have a constant need for oxygen and nutrients • Matrix metalloproteins and other enzymes become imbalanced • Results in multiple disorganized pores in tumor blood vessels and inflated gap junctions between endothelial cells • Microenvironment of the tumor • Cancer cells use glycolysis to provide nutrients • Acidic environment is created • pH-sensitive nanoparticles

  15. Active Targeting • Antigen expression of the tumor • Involves linking antibodies with nanoparticles that will bind with tumor antigens • Antibodies linked directly to drugs were not successful • Complimentary surface receptors must be located only on cancerous cells • Receptors must be expressed equally on all target cells • Receptors must never be shed into bloodstream

  16. Active Targeting • Internalization of nanoparticles • Ligand binds to receptor on tumor surface • Plasma membrane invaginates forming an endosome • Endosomes transported to target organelles • Bond between drugs and nanoparticles are broken by either hydrolysis or enzymes • Lysozymes are triggered when pH becomes acidic • Process bypasses protein pumps such as glycoprotein P

  17. Ligands to Target Cancer • Vitamin folate • Water-soluble vitamin from the B complex • Tranferrin • Serum glycoprotein that carriers iron through bloodstream into cells • Apatamers • Linked strands of oligonucleic acids (DNA or RNA) • Unique three-dimensional structures • Lectins • Proteins that attach to glycans on plasma membrane

  18. Where is all this going? • More personalized and effective methods of treating cancer • Avoiding harmful side-effects by targeting only tumor tissue • Cost efficiency • Viewing cancer as a network of interrelated events and not just as a pathway of events • Creating the ultimate nanoparticle capable of doing everything other nanoparticles can do

  19. References • Cho, K., Wang, X., Nie, S., Chen, Z., & Shin, D. M. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research, 14(5). doi: 10.1158/1078-0432.CCR-07-1441 • Heath, J. R., Davis, M. E., & Hood, L. (2009, February). Nanomedicine targets cancer. Scientific American, 44-51. • Heath, J. R., & Davis, M. E. (2008). Nanotechnology and cancer. Annual Review of Medicine, 59, 251-265. doi:10.1146/annurev.med.59.061506.185523 • Poh Hui, N. C. (2005). Nanomedicine and cancer. Retrieved October 22, 2009, from http://www.tahan.com/charlie/nanosociety/course201/nanos/NH.pdf • Steinmetz, N. F., Hong, V., Spoerke, E. D., Lu, P., Breitenkamp, K., Finn, M. G., et al. (2009). Buckyballs Meet Viral Nanoparticles: Candidates for Biomedicine [Electronic version]. Journal of the American Chemical Society, 131(47), 17093-17095. doi:10.1021/ja902293w

More Related